Thursday, 24 November 2022 08:30 AM
Company Update
NEWARK, DE / ACCESSWIRE / November 24, 2022 / A recently published study by FMI expects the global high potency API contract manufacturing market to augment at a 7% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 8 Billion is expected for the market.
Rising breakthroughs in high potency API (HPAPI) manufacturing technologies, combined with the quest for more effective drugs to improve patient outcomes, have significantly increased the number of HPAPIs in development pipelines, accelerating industry growth. Furthermore, a rising tendency in outsourcing operations due to greater risk management, lower costs, and the availability of modern ways to HPAPI controls has fueled growth.
From 2017 to 2021, the industry experienced noteworthy growth, registering a value CAGR of 5% and closing at US$ 6.5 Billion. The sector is seeing profitable expansion, and suppliers are quickly investing in new facilities and expanding their R&D laboratories. Piramal Pharm Solutions, for example, plans to expand its API and HPAPI research and manufacturing facilities in Michigan with increased capacity and additional capabilities in December 2020. To fulfill predicted demand, which included prospective possibilities, the corporation spent US$ 32 million in the plant. HPAPI regulatory oversight has grown stronger over time.
Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15786
Key Takeaways from the Market Study
- FMI projects the global high potency API Contract Manufacturing market to expand at a 7% value CAGR by 2032
- The global High Potency API Contract Manufacturing market is estimated at a market value of US$ 8 Billion
- The global high potency API contract manufacturing market is expected to garner a market value of US$ 16 Billion
- By application, oncology to experience major HPAPI contract manufacturing activities, yielding 63% of global revenue
"Demand for contract manufacturing of HPAPIs has expanded dramatically in recent years, and is one of the primary drivers of the global HPAPI market, owing to a rising number of prospective phase 3 drug candidates."Says an analyst at FMI
Market Competition
Piramal Pharma Solutions, Lonza, Catalent, Inc., VxP Pharma, Inc., Pfizer CentreOne, Gentec Pharmaceutical Group, AbbVie, Aurigene Pharmaceutical Services Ltd., CordenPharma International and Curia Global, Inc., are some prominent High Potency API Contract Manufacturing manufacturers.
- In June 2021, Lonza, for example, spent USD 21.5 billion in its Nansha, China, plant to enhance its API development and manufacturing capacity. Three 1,000 L GMP trains totalling 12 cu. ft. of reactor volume m. Additional expenditures will be made, as well as new research and GMP facilities capable of creating small-scale batches of highly effective APIs.
Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15786
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the global automotive axle market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of Product Type (Innovative and Generic), Synthesis (Synthetic and Biotech), Application (Oncology, Hormonal Disorders, Glaucoma and Others), Dosage Form (Injectable, Oral Solids, Creams and Others), across five major regions (North America, Latin America, Europe, Asia Pacific, South Asia, East Asia, Oceania and Middle East & Africa).
About the Healthcare Division at Future Market Insights
The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.
Key Segments Profiled in the High Potency API Contract Manufacturing Market Industry Survey
High Potency API Contract Manufacturing Market by Product Type:
- Innovative
- Generic
High Potency API Contract Manufacturing Market by Synthesis:
- Synthetic
- Biotech
High Potency API Contract Manufacturing Market by Application:
- Oncology
- Hormonal Disorders
- Glaucoma
- Others
High Potency API Contract Manufacturing Market by Dosage Form:
- Injectable
- Oral Solids
- Creams
- Others
Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15786
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
Report Preview@ https://www.futuremarketinsights.com/reports/high-potency-api-contract-manufacturing-market
More Trending Reports by Future Market Research:
Clinical Nutrition Market Size : The clinical nutrition market is projected to grow at a rate of 8.1% CAGR during the forecast period to surpass a valuation of US$ 19,727.4 Mn by 2028
Geriatric Care Services Market Share : Global demand for geriatric care services is anticipated to document a CAGR of 6.0% during the period of 2022-2032.
Digital Therapeutics Market Trends : The global digital therapeutics market is set to reach a valuation of US$ 4.8 Bn in 2022. Expanding at an impressive 24.4% CAGR over the forecast period, total sales in the digital therapeutics market will reach US$ 42.5 Bn by 2032.
Healthcare Biometrics Market Growth : The healthcare biometrics market is anticipated to grow with a CAGR of 18.1% from 2022 to 2032. The healthcare biometrics market share is likely to boost up to US$ 3.4 Bn in 2022.
Central Lab Market Analysis : The global central lab market is expected to reach around US$ 2.42 Billion in 2022. With rapid surge in clinical trials worldwide, the overall market is anticipated to grow at a healthy CAGR of around 6% between 2022 and 2032, surpassing US$ 4.0 Billion by the end of 2032.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
SOURCE: Future Market Insights, Inc.